CEOs’ lack of confidence in cybersecurity resilience may hinder growth
A recent report titled “The Cyber-Resilient CEO” by Accenture (NYSE:ACN) reveals a paradox in the mindset of global CEOs regarding…
Earnings call: Citi reports robust Q3 2023 results, announces organizational changes and new digital asset solution
In the third quarter of 2023, Citigroup (NYSE:C) reported a net income of $3.5 billion, with earnings per share (EPS)…
Samsung set to lead in 2nm chip production as TSMC faces delays
In the race for next-generation chip development, Samsung Electronics (KS:005930) appears poised to take the lead with plans to introduce…
Earnings call: Wells Fargo reports Q3 2023 financial improvement, anticipates regulatory changes
Wells Fargo’s CEO, Charlie Scharf, announced during the company’s third-quarter 2023 earnings conference call that the firm has seen an…
Earnings call: Oil-Dri Corporation of America reports record sales and earnings for fiscal year 2023
Oil-Dri Corporation of America reported a record-breaking performance in its fiscal year 2023, with substantial increases in sales and earnings.…
UAW strike could upend GM, Ford financial strategies
(Reuters) – General Motors (NYSE:GM) and Ford (NYSE:F) have laid out ambitious plans to spend billions developing new electric vehicles…
Novo Nordisk in $1.3 billion deal to buy hypertension drug
(Reuters) – Novo Nordisk (NYSE:NVO) has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular…
Chip stocks fall as U.S. prepares to strengthen export restrictions on China
U.S. chip stocks like Nvidia (NASDAQ:NVDA), and Advanced Micro Devices (NASDAQ:AMD), among others, are trading lower early Monday following a…
Apple stock falls on reports Huawei gaining bigger-than-expected market share in China
Apple’s (NASDAQ:AAPL) new iPhone 15 is facing challenges in the Chinese market, with sales lagging behind its predecessor – the…
Pfizer drops after cutting guidance; reset event prompts Jefferies to upgrade stock to Buy
Pfizer Inc (NYSE:PFE) shares lost more than 3% in premarket trading after the healthcare giant revised its revenue and earnings…